Clinical Trials Logo

Obese clinical trials

View clinical trials related to Obese.

Filter by:

NCT ID: NCT05819853 Recruiting - Obese Clinical Trials

Role of Semaglutide in Restoring Ovulation in Youth and Adults With Polycystic Ovary Syndrome

RESTORE
Start date: November 3, 2023
Phase: Phase 3
Study type: Interventional

Girls and women 12-35 years old with obesity and polycystic ovarian syndrome who are on or off metformin, will receive a glucagon like peptide-1 receptor agonist intervention for 10 months to induce metabolic changes, weight loss and improve reproductive abnormalities.

NCT ID: NCT05775003 Recruiting - Weight Loss Clinical Trials

Effects of Adding L-BAIBA or L-BAIBA + Grains of Paradise to Exercising Adult Overweight and Obese Men and Women

GOP
Start date: April 11, 2023
Phase: N/A
Study type: Interventional

The goal of this intervention study is to examine changes in body composition, weight loss, and cardio-metabolic risk factors after adding supplementation of L-Beta aminoisobutyric acid (L-BAIBA) and Grains of Paradise to exercise in overweight and obese men and women. Participants will supplement for 8 weeks and complete a 8 week exercise protocol.

NCT ID: NCT05770791 Recruiting - Obese Clinical Trials

Comparative Effects of Using Black Seed and Cumin Seed on BCP of Obese Grade I

Start date: January 27, 2023
Phase: Phase 1
Study type: Interventional

The goal of this Randomized clinical trial is to compare effectiveness of of using black seed (Nigella sativa) and cumin seed (Cuminum cyminum) on Body composition profile of obese grade 1. The primary objective of this study is To compare effectiveness of of using black seed (Nigella sativa) and cumin seed (Cuminum cyminum) on Body composition profile of obese grade 1. Subjects will be given a consent form and after subjects read and sign the informed consent, they would be included in study according to eligibility criteria.

NCT ID: NCT05770570 Recruiting - Obesity Clinical Trials

Taxi ROADmAP (Realizing Optimization Around Diet And Physical Activity)

Start date: December 22, 2022
Phase: Phase 2
Study type: Interventional

The researchers will conduct 'Taxi ROADmAP (Realizing Optimization Around Diet And Physical activity)', which also utilizes MOST, and the same 4 obesity intervention components as in SANOS, but targets the overweight/obesity crisis in another at-risk, low socioeconomic status (SES) population, taxi and for-hire vehicle (FHV) drivers (Lyft, Uber, etc.). ROADMAP also utilizes an effectiveness- implementation hybrid type 1 design. Hybrid trials, which blend effectiveness and implementation studies, can lead to more rapid translational uptake and more effective implementation. Taxi and FHV drivers are a growing, multilingual, hard-to-reach, predominantly immigrant and minority essential worker population. There are over 750,000 licensed taxi and FHV drivers in in the U.S. and over 185,000 in New York City (NYC). They have higher rates of overweight/obese range body mass index (BMI) than New Yorkers in general (77% vs 56%) and have high rates of elevated waist circumference, sedentary behavior, poor diets, and health care services underutilization. ROADmAP will test 4 evidence- and theory-based (Social Cognitive Theory [SCT]) behavior change intervention components. We will use MOST to identify which of the 4 components contribute most significantly and cost-effectively to weight loss among NYC drivers recruited at workplace health fairs (HFs) and virtually. Objectives are to apply MOST to design an optimized version of a scalable, lifestyle intervention for taxi/FHV drivers, and then to conduct a mixed methods multistakeholder process evaluation to facilitate widespread intervention implementation.

NCT ID: NCT05493345 Recruiting - Clinical trials for Diabetes Mellitus, Type 2

Active Communities - Adherence to Physical Activity

Start date: August 5, 2022
Phase:
Study type: Observational

The primary aim of this study is to investigate whether a number of co-created bridge-building activities between municipality-based lifestyle programs and community-based physical activities (e.g. local sports and exercise associations) can support persons with type 2 diabetes, cardiovascular disease and/or obesity in maintain physical activity levels.

NCT ID: NCT05408728 Recruiting - Healthy Clinical Trials

Dietary Sugar Absorptive Phenotype for Prediction of Weight Loss Outcome

Start date: July 10, 2022
Phase:
Study type: Observational

This study is trying to determine whether the success of bariatric surgery can be predicted by evaluating the dietary sugar absorptive characteristics in the small intestine and if there is any gene expression change on the dietary sugar absorptive characteristics.

NCT ID: NCT05392920 Recruiting - Obese Clinical Trials

Determination of the Validity of One-Minute Sit-to-Stand Test in Obese and Overweight Children and Adolescents

Start date: July 8, 2022
Phase:
Study type: Observational

Obese individuals need to be evaluated comprehensively before exercise programs are determined. Determination of exercise intolerance is important for the detection of functional limitations. One minute sit to stand test (1MSTST) can be used as an alternative to cardiopulmonary exercise tests (CPET) or field tests. It is easy to use, quick to apply, valid and reliable, and applicable even in small areas. In addition, it is a simple assessment adequate for children's needs and behaviors and can be easily applied both in the clinic and at home, making it easier to use in children. Studies have shown that 1MSTST is a valid test in chronic obstructive pulmonary disease (COPD), cystic fibrosis, interstitial lung disease, and, healthy children and adolescents. However, no study has been found regarding the validity of its use in obese children and adolescents.The aim of our study is to investigate the validity and reliability of 1MSTST in overweight-obese children and adolescents.

NCT ID: NCT05385978 Recruiting - Obese Clinical Trials

A Study of Distal Jejunal-release Dextrose in Obese Participants

Start date: July 1, 2022
Phase: Phase 2
Study type: Interventional

The primary purpose of the study is to evaluate the efficacy and safety of APHD-012 (distal jejunal-release dextrose [Aphaia technology, AT]) in obese participants.

NCT ID: NCT05347030 Recruiting - Overweight Clinical Trials

Acupuncture for Impaired Glucose Tolerance in Overweight/Obese Population

Start date: October 6, 2022
Phase: N/A
Study type: Interventional

This is a prospective, multicenter, parallel-group, participants- and assessors-blinded randomized trial aiming to evaluate the effectiveness and safety of acupuncture in improving glucose metabolism for overweight/obese Participants with IGT, in comparison with sham acupuncture.

NCT ID: NCT05316467 Recruiting - Overweight Clinical Trials

Weight Management Plus Megestrol Acetate in Early-stage Endometrioid Carcinoma

Start date: May 1, 2022
Phase: Phase 2/Phase 3
Study type: Interventional

To investigate the efficacy of weight management plus megestrol acetate in obese patients with early endometrioid carcinoma(EEC)asking for fertility-sparing treatment